Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate for coronary artery disease progression in type 2 diabetes
NCT02607436Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jul 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in coronary artery disease (CAD), sponsored by Seoul National University Bundang Hospital. Started Jul 2015; status: completed.
02
Drugs
sarpogrelate
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02607436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607436.